All Infection Prevention & Control articles – Page 13
-
NewsFirst clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis
Scientists have published the results of a phase IIa pilot clinical trial assessing ibuprofen as a host-directed therapy in patients with pre-extensively drug-resistant tuberculosis (pre-XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
-
NewsHelpful microbes could battle pathogens in our hospitals and schools - with the help of AI to make it work
Helpful microbes that combat harmful pathogens could be the answer to rising antimicrobial resistance, particularly within built environments such as hospitals, homes and schools, says a new review.
-
NewsNew antiseptic capable of eliminating 99.9% of Candida parapsilosis cells
A 0.5% alcohol-based chlorhexidine antiseptic, combined with the natural organic compounds eugenol and menthol, can eliminate 99.9% of Candida parapsilosis cells. This fungus is one of the leading causes of infections in hospital settings.
-
NewsTwo companion papers explain immune ‘exhaustion’ - and how we might prevent it
Chronic and viral infections can literally exhaust certain key cells in the immune system from a constant barrage of attacks. But a new pair of papers has now pointed a way to understand how this exhaustion happens at a molecular level.
-
NewsInternational study maps high risk hotspots of Noma disease in Nigeria
A collaborative international research team has now produced the most detailed mapping of noma incidence risk in Nigeria, uncovering previously unrecognised high-risk areas and providing an important new tool to support prevention and early detection efforts.
-
NewsBrazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment
Following a licensing agreement signed between the Serum Institute of India (SII) and DNDi, a Phase III clinical trial is expected to begin early next year, with the aim of developing a safe, effective, and globally accessible therapeutic for dengue.
-
NewsChikungunya fever: Etiology, pathogenesis, and management, with evidence-based application of traditional Chinese medicine
Traditional Chinese medicine (TCM) offers complementary strategies for acute symptoms and chronic polyarthralgia in Chikungunya infection. A review synthesizes current knowledge on etiology, pathogenesis, clinical features, and management.
-
NewsHow immune cells in our gut mesentery fight salmonella
Researchers have found that immune cells in a portion of the abdominal cavity, called the mesentery, play a critical role in suppressing — or exacerbating — salmonella infection.
-
NewsBiochar ‘switches on’ natural oxygen chemistry to suppress soil-borne pathogens and reshape healthier microbial communities
A new study reveals how specially prepared biochar can directly suppress a destructive soil-borne pathogen while helping rebuild a richer and more stable soil bacterial community.
-
NewsBronchiectasis and NTM Research Registry data featured in four World Bronchiectasis Conference abstracts
The Bronchiectasis and NTM Association announced that research leveraging data from the Bronchiectasis and NTM Research Registry was featured in four abstracts presented at the World Bronchiectasis Conference.
-
NewsNew study advances dry mRNA vaccine patch design
New research could help make future mRNA vaccines easier to store and distribute. The study identified conditions that help protect the particles that carry mRNA in dry vaccine patches, offering practical guidance for future patch design.
-
NewsFighting the world’s deadliest infection with PAC-MAN and AI
Researchers have developed techniques that can speed up the search for better tuberculosis drugs. They first measure which chemical compounds are able to slip across the outer membrane and then use those measurements to predict other compounds that can get into the Mtb cell.
-
NewsTuberculosis vaccine changes brain’s immune environment and Alzheimer’s biomarkers in older adults
A study shows that BCG vaccines can alter immune responses and amyloid-beta biomarkers in non-Alzheimer’s participants, which may help explain previously observed links to lower disease risk.
-
NewsNew HIV vaccine shows unprecedented success in preclinical study
Scientists have developed an HIV vaccine that trains immune cells to see past HIV’s defenses. This HIV vaccine works by prompting the body’s immune system to make substantial numbers of rarely seen “broadly neutralizing” antibodies.
-
NewsPreparing for Andes virus outbreaks to prevent transmission in healthcare settings
Researchers examined past cases to help healthcare facilities and public health agencies prepare for future Andes virus outbreaks like the one that caused a cruise ship outbreak earlier this year.
-
NewsNo entry: Blocking viruses from entering cells
The Volkswagen Foundation funds a project by UdS, HIPS, and HZI to create an innovative platform for developing viral entry inhibitors—specifically targeting respiratory viruses and other viruses that pose a pandemic risk.
-
NewsKorea University College of Medicine Vaccine Innovation Center selected to lead KDCA-funded hantavirus vaccine development project
The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.
-
NewsResearchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk
New research has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.
-
News ABM strengthens Irish life sciences business with major multi-site life sciences contract
ABM, a leading international provider of facility, engineering, and infrastructure solutions, has secured a major multi-site services agreement with a leading global life sciences company operating manufacturing facilities across Ireland.
-
NewsScripps Research scientists awarded $2M to advance global disease surveillance
Two Gates Foundation grants will expand wastewater surveillance and AI-driven disease monitoring to support faster public health responses worldwide.